Exclusive Pharma Industry 4 min read After WHO nod, Indian Patient Groups urge GLP-1 inclusion in NLEM With the WHO recommending blockbuster GLP-1 therapies such as Semaglutide and Tirzepatide as essential medicines for diabetes, patient advocates in India are urging their inclusion in the National List of Essential Medicines (NLEM) to enable state procurement, free distribution, and wider affordability
Frequently asked questions What is the CJC-1295 + Ipamorelin Blend
Individuals who are genetically predisposed to a dysfunctional gut barrier are therefore more susceptible to developing inflammatory gut disorders (Knig et al
Coated peptides were used against the MDA-MB-231 breast cancer cell line
The same hormone therapy and strength training we use for weight management also protects bone density, reducing osteoporosis risk
For those lacking adequate insurance coverage, Klinic offers competitive self-pay rates, starting self-pay options for Foundayo at $149 monthly and assisting with manufacturer savings programs and copay cards